AXP vs CRNX · P/E 20, rev $21.73B vs rev $7.7M
American Express Company (AXP) versus Crinetics Pharmaceuticals Inc (CRNX) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. CRNX currently screens at market cap $2.76B.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. CRNX currently screens at market cap $2.76B.
Not investment advice. Open the AXP and CRNX stock pages for the full models.
Not investment advice.